Published Date: 
Aug,2017
Total Pages: 
150
Categories: 
Medical Devices
Report Id: MPDM817

PCR systems have made prepared for progression in life sciences investigate and nuclear diagnostics through its most potential components, for instance, incomparable distinguishing proof and estimation of innate materials, for instance, DNA and RNA. Researchers can assess and explore remarkable alleles and point changes using advanced PCR frameworks, for instance, progressed PCR. Makers are possessed with making PCR framework with redesigned capacities, for instance, wide menu of tests, higher affectability and specificity. Other genuine advances related with the PCR fuse shorter turnaround times (PCR cycling time), higher benefit and robotized work process; as needs be ensuring capable area and increase of inherited materials with exact results.

 

How Big is The Global PCR Devices Market?

 

The Global PCR Devices Market is expected to exceed more than US$ 5.31 Billion by 2022 at a CAGR of 8.9% in the given forecast period.

 

The major driving factors of Global PCR Devices Market are as follows:

 

  • Innovative technological advancements in PCR technology
  • Genetic Disorders and Infectious Diseases are growing
  • In developing economies market penetration is growing
  • Growing public and private investments
  • For Disease Diagnostics use of biomarker profiling is raising

 

The restraining factors of Global PCR Devices Market are as follows:

 

  • Technical limitations
  • Cost of associated devices is high
  • Unskilled labor and improper data analytical tools
  • New technologies increases competition

 

The Global PCR Devices Market is segmented on the lines of its technology, treatment, application and regional. Based on technology segmentation it covers Quantitative PCR (qPCR) and Digital PCR (dPCR). On product segmentation it covers Quantitative PCR (qPCR) it includes Instruments, Reagents and Consumables, Software and Services where as in Digital PCR (dPCR) Includes Instruments, Reagents and Consumables, Software and Services. On application basis it covers Quantitative PCR (qPCR), it includes Clinical applications, Research application and Forensic application in Digital PCR (dPCR) includes Clinical applications, Research application and Forensic application. On the segmentation of end users it covers Quantitative PCR (qPCR) which includes Research Laboratories and Academic Institutes, Pharma and Biotech Companies, Hospitals and Diagnostic Centers, Clinical Research Organizations and Forensic Laboratories where as Digital PCR (dPCR) includes Academic Institutes, Pharma and Biotech Companies, Hospitals and Diagnostic Centers, Clinical Research Organizations and Forensic Laboratories. The Global PCR Devices Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

 

This report provides:
 
1) An overview of the global market for PCR Devices Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for PCR Devices Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

 

Report scope:

The scope of the report includes a detailed study of global and regional markets on PCR Devices Market with the reasons given for variations in the growth of the industry in certain regions.
 
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include PCR (qPCR) market include Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Danaher Corporation (U.S.), Takara Bio Inc. (Japan),Thermo Fisher Scientific Inc. (U.S.),  bioMérieux S.A. (France), Fluidigm Corporation (U.S.), Abbot Laboratories (U.S.), and Agilent Technologies, Inc. (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
 
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

 

The Global PCR Devices Market has been segmented as below:

 

By Technology Analysis:

  • Quantitative PCR (qPCR)
  • Digital PCR (dPCR)

 

By Product Analysis:

  • Quantitative PCR (qPCR)
    • Instruments
    • Reagents and Consumables
    • Software and Services
  • Digital PCR (dPCR)
    • Instruments
    • Reagents and Consumables
    • Software and Services

 

By Application Analysis

  • Quantitative PCR (qPCR)
    • Clinical Applications
      • Pathogen Testing
      • Oncology Testing
      • Blood Screening
      • Other Clinical Applications
    • Research Applications
    • Forensic Applications
  • Digital PCR (dPCR)
    • Clinical Applications
      • Pathogen Testing
      • Oncology Testing
      • Blood Screening
      • Other Clinical Applications
    • Research Applications
    • Forensic Applications

 

By End User Analysis:

  • Quantitative PCR (qPCR)
    • Research Laboratories and Academic Institutes
    • Pharma and Biotech Companies
    • Hospitals and Diagnostic Centers
    • Clinical Research Organizations
    • Forensic Laboratories
  • Digital PCR (dPCR)
    • Research Laboratories and Academic Institutes
    • Pharma and Biotech Companies
    • Hospitals and Diagnostic Centers
    • Clinical Research Organizations
    • Forensic Laboratories

 

By Regional Analysis:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

Reasons to Buy this Report:
 
1) Obtain the most up to date information available on all Global PCR Devices Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global PCR Devices Market data.
4) Assess your competitor’s refining portfolio and its evolution.

 

Customization:
We can offer you custom research reports as per client’s special requirements.

1    INTRODUCTION    
    1.1    KEY TAKE AWAYS    
    1.2    REPORT DESCRIPTION    
    1.3    MARKETS COVERED    
    1.4    STAKEHOLDERS    
    1.5    RESEARCH METHODOLOGY    
    1.5.1    MARKET SIZE    
    1.5.2    MARKET SHARE    
    1.5.3    KEY DATA POINTS FROM SECONDARY SOURCES    
    1.5.4    KEY DATA POINTS FROM PRIMARY SOURCES 

2 Research Methodology 
    2.1 Research Data 
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Factor Analysis 
           2.2.1 Introduction
           2.2.2 Demand-Side Analysis
                    2.2.2.1 Healthcare Expenditure Patterns
                    2.2.2.2 Rapid Growth of Aging Population
                    2.2.2.3 Incidence and Prevalence of Cancer
                    2.2.2.4 Birth Rate/Pregnancies
                    2.2.2.5 Burden of Infectious Diseases
                    2.2.2.6 Number of Clinical, Forensics, and Research Laboratories
           2.2.3 Supply-Side Analysis
                    2.2.3.1 Number of Product Launches: qPCR and dPCR vs Competitive Technologies
                    2.2.3.2 Parent Market Analysis: Polymerase Chain Reaction (PCR) Market
    2.3 Market Size Estimation 
           2.3.1 Top-Down Approach
           2.3.2 Bottom-Up Approach
                    2.3.2.1 Bottom-Up Approach: dPCR and qPCR Instruments and Software
                    2.3.2.2 Bottom-Up Approach: dPCR and qPCR Reagents
    2.4 Data Triangulation 
    2.5 Research Assumptions

3 Executive Summary 
    3.1 Introduction 
    3.2 Conclusion

4 Premium Insights 
    4.1 dPCR and qPCR Market Overview (2017-2022) 
    4.2 Global qPCR and dPCR Technology Market, By Region 2017 Vs.2022 (USD Million) 
    4.3 Global qPCR and dPCR Market Share, By Product and Service (2017) 
    4.4 Regional Analyiss: qPCR Market, By Application, 2017 vs 2022 (USD Million) 
    4.5 Regional Analysis: dPCR Market, By Application, 2017 vs 2022 (USD Million)

5 Market Overview 
    5.1 Introduction 
    5.2 Technological Evolution in qPCR/dPCR 
    5.3 Market Dynamics 
           5.3.1 Major Market Drivers
                    5.3.1.1 Rising Incidences of Infectious Diseases and Genetic Disorders
                    5.3.1.2 Technological Advancement in PCR Technologies
                    5.3.1.3 Increasing Public-Private Investments, Funds, and Grants
                    5.3.1.4 Increasing Use of Biomarker Profiling for Disease Diagnostics
                    5.3.1.5 Successful Completion of the Human Genome Project
           5.3.2 Major Market Restraints
                    5.3.2.1 High Device Costs Associated With dPCR
                    5.3.2.2 Technical Limitations of qPCR and dPCR Techniques
           5.3.3 Major Market Opportunities
                    5.3.3.1 Growing Market Penetration in Emerging Countries
                    5.3.3.2 Shift From Plant-Derived to Genome-Based Drug Discovery
           5.3.4 Major Market Challenges
                    5.3.4.1 Adoption and Implementation of Miqe Guidelines for Publishing qPCR and dPCR-Based Research

6 Industry Trends 
    6.1 Introduction 
    6.2 Value Chain Analysis 
    6.3 Industry Trends 
           6.3.1 Development of Lab-On-Chip PCR Devices
           6.3.2 Ongoing Technological Integration With PCR Process
    6.4 Porter’s Five Forces Analysis 
           6.4.1 qPCR Market: Porter’s Five Forces Analysis
           6.4.2 dPCR Market: Porter’s Five Forces Analysis

7 Global qPCR and dPCR Market, By Technology 
    7.1 Introduction 
    7.2 Quantitative PCR (qPCR) 
    7.3 Digital PCR (dPCR)

8 Global qPCR and dPCR Market, By Product and Service 
    8.1 Introduction 
    8.2 qPCR Products and Services 
           8.2.1 qPCR Reagents and Consumables
           8.2.2 qPCR Instruments
           8.2.3 qPCR Software and Services
    8.3 dPCR Products and Services 
           8.3.1 dPCR Instruments
           8.3.2 dPCR Reagents and Consumables
           8.3.3 dPCR Software and Services

9 qPCR and dPCR Market, By Application 
    9.1 Introduction 
    9.2 qPCR Applications 
           9.2.1 Clinical Applications
                    9.2.1.1 Pathogen Testing
                    9.2.1.2 Oncology Testing
                    9.2.1.3 Blood Screening
                    9.2.1.4 Other Clinical Applications
           9.2.2 Research Applications
           9.2.3 Forensic Applications
    9.3 dPCR Applications 
           9.3.1 Clinical Applications
                    9.3.1.1 Pathogen Testing
                    9.3.1.2 Oncology Testing
                    9.3.1.3 Blood Screening
                    9.3.1.4 Other Clinical Applications
           9.3.2 Research Applications
           9.3.3 Forensic Applications

10 qPCR and dPCR Market, By End User
     10.1 Introduction 
     10.2 Quantitative PCR (qPCR) End Users 
             10.2.1 Hospitals and Diagnostic Centers
             10.2.2 Research Laboratories and Academic Institutes
             10.2.3 Pharmaceutical and Biotechnology Companies
             10.2.4 Clinical Research Organizations
             10.2.5 Forensic Laboratories
     10.3 Digital PCR (dPCR) End Users 
             10.3.1 Research Laboratories and Academic Institutes
             10.3.2 Hospitals and Diagnostic Centers
             10.3.3 Pharmaceutical and Biotechnology Companies
             10.3.4 Clinical Research Organizations
             10.3.5 Forensic Laboratories

11 qPCR and dPCR Market, By Region 
     11.1 Introduction 
     11.2 North America 
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe 
             11.3.1 Germany
             11.3.2 U.K.
             11.3.3 France
             11.3.4 Rest of Europe
     11.4 Asia-Pacific 
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of APAC (RoAPAC)
     11.5 Rest of the World (RoW)

12 Competitive Landscape 
     12.1 Overview 
     12.2 Vendor Inclusion Criteria 
     12.3 Competitive Leadership Mapping 
             12.3.1 Visionary Leaders
             12.3.2 Innovators
             12.3.3 Dynamic Differentiators
             12.3.4 Emerging Companies
     12.4 Competitve Benchmarking 
             12.4.1 Analysis of Product Portfolio of Major Players in the dPCR and qPCR Market (25 Players)
             12.4.2 Business Strategies Adopted By Major Players in the dPCR and qPCR Market (25 Players)
     12.5 Market Share Analysis 
             12.5.1 qPCR Market Share Analysis (2016)
             12.5.2 dPCR Market Share Analysis (2016)

13 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
     13.1 Introduction 
     13.2 F. Hoffman-La Roche Ltd. 
     13.3 Thermo Fisher Scientific, Inc. 
     13.4 Bio-Rad Laboratories, Inc. 
     13.5 Qiagen N.V. 
     13.6 Takara Bio, Inc. 
     13.7 Agilent Technologies, Inc. 
     13.8 Biomérieux S.A. 
     13.9 Fluidigm Corporation 
     13.10 Danaher Corporation 
     13.11 ABBott Laboratories 
     13.12 Merck KGaA 
     13.13 Becton Dickinson and Company 
     13.14 Promega Corporation 
     13.15 Meridian Bioscience, Inc. (Bioline Reagents Ltd.) 
     13.16 Analytik Jena AG (Endress+Hauser Ag)

License Format Properties
Single User License The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.
Multi User License The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user license, allowing up to five users to have access to the product.
Corporate License The report will be emailed to you. The report is sent in PDF format. This is a 10+ user license, allowing up to 10+ users to have access to the product.
Mini Report License In this you will receive full report except the Company Profile section of this report. In this you will receive full report except the Company Profile section of this report.
Need More Information: 

Email: Sales@marketresearchengine.com

Toll Free No. : +1-855-984-1862

Call Us. : +91 86 05 657204